Cephalosporin C Sodium Salt CAS 51762-04-0
Assay: 95%min
Appearance: white powder
Packaging: 25KG/Drum
Sample: available
发送询盘
Description
Cephalosporin C Sodium Salt
Cephalosporin C Sodium Salt Quick Detail
CAS No.: 51762-04-0
Other Names: oct-2-ene-2-carboxylate
Appearance: white powder
MF: C16H20N3NaO8S, C16H20N3NaO8S
MW: 437.40007
EINECS No.: 257-390-2
Chemical Structure:
Cephalosporin C Sodium Salt Basic Properties
Isotope mass
415.104935
Number of hydrogen bond donors
4
Number of hydrogen bond acceptors
10
Number of heavy atoms
28
Number of rotatable chemical bonds
10
Determine the number of atomic stereo centers
3
Hydrophobic parameter calculation reference value (XlogP)
4.4
Topological molecular polar surface area
202
Cephalosporin C Sodium Salt Usage
Animal Pharmaceuticals.
Cephalosporin C Sodium Salt Package
25Kg/drum or by customer??s requirement.
Cephalosporin C Sodium Salt Storage
Storage Conditions: Store in a cool,dry,well-ventilated place.
5 |
|
0 |
4 |
|
0 |
3 |
|
0 |
2 |
|
0 |
1 |
|
0 |
- 2
- 2-diallylpent-4-en-1-amine
- 4
- 95-16-9
- Ammonium sulfamate
- Benzothiazole
- cas:67889-00-3ح2
- cas:83524-75-8 | pigment black 32
- cas:928836-00-4 | 2
- cas:932745-70-5 | 4
- Chemical Minerals
- Coconut diethanolamide
- Daily Chemicals
- discount
- for sale
- General pvc resin
- hexyl D-glucoside
- in stock
- Lauramidopropyl betaine
- LAURIC ACID MONOETHANOLAMIDE
- Petroleum Additives
- Plasticiser
- Ploymers
- price
- PVC
- quotation
- Raw Materal
- Remove term: Petroleum Additives Petroleum Additive
- SODIUM ETHYL 2-SULFOLAURATE
Related Products
Chemical Name: Tylosin tartrate
CAS No.:?74610-55-2
Appearance:?white powder
Assay????98.0%
Levodopa, also known as L-DOPA or 3,4-dihydroxy-L-phenylalanine, is a naturally occurring amino acid and a critical precursor in the biosynthesis of the neurotransmitters dopamine, norepinephrine, and epinephrine. With the molecular formula C9H11NO4, levodopa is a large, neutral amino acid that plays a significant role in the treatment of Parkinson’s disease due to its ability to cross the blood-brain barrier and be converted into dopamine.
Chemically, levodopa is synthesized from the precursor amino acid tyrosine through the action of the enzyme tyrosine hydroxylase. As a medication, levodopa is often formulated with a peripheral DOPA decarboxylase inhibitor to reduce its conversion to dopamine outside the brain, thereby increasing its effectiveness and reducing side effects.
Levodopa is characterized by its effectiveness in alleviating the motor symptoms of Parkinson’s disease, such as tremors, rigidity, and bradykinesia. It is typically administered orally and absorbed from the gastrointestinal tract, where it is then transported to the brain.
In summary, levodopa is a vital pharmaceutical compound used in neurology for its role in treating Parkinson’s disease by replenishing the brain’s dopamine levels. Its targeted delivery and conversion to dopamine make it an essential treatment option for managing the motor symptoms associated with this condition.
Chemical Name: Imazalil Sulfate
CAS No.: 58594-72-2
Molecular Formula: C14H14Cl2N2O.H2SO4
Molecular Weight: 395.26
Appearance: Solid
Product name:HYDROXYPROPYL GUAR HYDROXYPROPYLTRIMONIUM CHLORIDE
Purity:99%
Appearance:Light Yellow Powder
Package:Customized according to customer needs.
Sample:Available
Common English name: 5-iodo-2,3-dihydropyridazin-3-one
CAS No.: 825633-94-1
Molecular formula: C4H3IN2O
Molecular weight: 221.98
Sample: Available
Chemical Name: UV-120
Other Name: (2’,4’-Di-tert-butylphenyl 3,5-di-tert-butyl-4-hydroxybenzoate)
CAS No.: 4221-80-1
Molecular Fomula: C29H42O3
Molecular weight: 438.66
Assay: ≥99%(LC)
Levodopa, also known as L-DOPA or 3,4-dihydroxy-L-phenylalanine, is a naturally occurring amino acid and a critical precursor in the biosynthesis of the neurotransmitters dopamine, norepinephrine, and epinephrine. With the molecular formula C9H11NO4, levodopa is a large, neutral amino acid that plays a significant role in the treatment of Parkinson’s disease due to its ability to cross the blood-brain barrier and be converted into dopamine.
Chemically, levodopa is synthesized from the precursor amino acid tyrosine through the action of the enzyme tyrosine hydroxylase. As a medication, levodopa is often formulated with a peripheral DOPA decarboxylase inhibitor to reduce its conversion to dopamine outside the brain, thereby increasing its effectiveness and reducing side effects.
Levodopa is characterized by its effectiveness in alleviating the motor symptoms of Parkinson’s disease, such as tremors, rigidity, and bradykinesia. It is typically administered orally and absorbed from the gastrointestinal tract, where it is then transported to the brain.
In summary, levodopa is a vital pharmaceutical compound used in neurology for its role in treating Parkinson’s disease by replenishing the brain’s dopamine levels. Its targeted delivery and conversion to dopamine make it an essential treatment option for managing the motor symptoms associated with this condition.
Chemical Name: Zinc citrate
Synonyms: Zinc citrate trihydrate
CAS No.: 546-46-3
Molecular Formula: C6H8O7Zn
Molecular Weight: 257.5
Appearance: White powder
Chemical Name: Ashwagandha Extract
Synonyms: Withania somnifera, ext.; Withania Somnefera Extract
CAS: 90147-43-6
Appearance: Brown
Product name:Cyclopentane
Purity:96%
Appearance:White powder
Package:25kg/bag
Sample:Available
Chemical Name: Potassium Castorate
CAS No.: 8013-05-6
Molecular Formula: C57H107K3O12
Molecular Weight: 1101.74718
Appearance: Yellow Liquid
Chemical Name:Sodium Stibogluconate
CAS No.:16037-91-5
Appearance:?White liquid
Assay??99.0%
Reviews
There are no reviews yet.